About Recourse Biologics
Recourse Biologics is a private company based in Houston, Texas, incorporated in 2024 in Delaware. It has reported $2,786,350 raised in one offering on Form D since October 2024. Its chief executive is Daniel Watkins.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 26, 2024 | Oct 8, 2024 | $2,786,350of $4.3M target | 14 | $199K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Recourse Biologics's Form D filed Oct 8, 2024.
AK
DW
Daniel Watkins
President and Co-Chief Executive Officer, director
Also an executive officer and director at AskY Therapeutics.
JW